A new future for patients with cystic fibrosis

This month’s installment of “The AJT Report” reports on promising advancements for patients with cystic fibrosis who are awaiting lung transplants, including a recently FDA-approved treatment. We also update readers on COVID-19 resources currently available on the AJT website and elsewhere.

Detalles Bibliográficos
Autor principal: Pullen, Lara C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2020
Materias:
The AJT Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800707/
https://www.ncbi.nlm.nih.gov/pubmed/32333514
http://dx.doi.org/10.1111/ajt.15893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800707/
https://www.ncbi.nlm.nih.gov/pubmed/32333514
http://dx.doi.org/10.1111/ajt.15893

Ejemplares similares